CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ReMAP-PD aims to validate a human-based brain-on-chip platform for testing new therapeutics against Parkinson's disease. This innovative model adheres to ethical standards and seeks to replace animal testing, enhancing the development of effective treatments for this neurodegenerative condition.
Parkinson's disease (PD), a highly incapacitating neurodegenerative condition of complex and multifactorial origins, remains incurable.
As PD cases have skyrocketed by circa 160% since 1990, the burden on society grows heavier.
The lack of reliable systems to test new therapeutics, allied with the limitations of current animal gold standard models, have eluded the development of safe and efficacious molecules to fight PD.ReMAP-PD aims at validating a novel 3Rs Microphysiological Alternative Plat…
UNIVERSIDADE NOVA DE LISBOA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
